GHRS
Price
$11.04
Change
-$0.23 (-2.04%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
699.06M
89 days until earnings call
MDGL
Price
$267.34
Change
-$6.01 (-2.20%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
6.07B
75 days until earnings call
Interact to see
Advertisement

GHRS vs MDGL

Header iconGHRS vs MDGL Comparison
Open Charts GHRS vs MDGLBanner chart's image
GH Research
Price$11.04
Change-$0.23 (-2.04%)
Volume$3.72K
Capitalization699.06M
Madrigal Pharmaceuticals
Price$267.34
Change-$6.01 (-2.20%)
Volume$3.93K
Capitalization6.07B
GHRS vs MDGL Comparison Chart
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. MDGL commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Hold and MDGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (GHRS: $11.27 vs. MDGL: $273.35)
Brand notoriety: GHRS and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 105% vs. MDGL: 85%
Market capitalization -- GHRS: $699.06M vs. MDGL: $6.07B
GHRS [@Biotechnology] is valued at $699.06M. MDGL’s [@Biotechnology] market capitalization is $6.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, GHRS is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 6 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • GHRS’s TA Score: 6 bullish, 4 bearish.
  • MDGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GHRS is a better buy in the short-term than MDGL.

Price Growth

GHRS (@Biotechnology) experienced а +5.33% price change this week, while MDGL (@Biotechnology) price change was -6.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

GHRS is expected to report earnings on Aug 20, 2025.

MDGL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.07B) has a higher market cap than GHRS($699M). GHRS YTD gains are higher at: 61.000 vs. MDGL (-11.414). GHRS has higher annual earnings (EBITDA): -41.75M vs. MDGL (-376.15M). MDGL has more cash in the bank: 843M vs. GHRS (291M). GHRS has less debt than MDGL: GHRS (658K) vs MDGL (120M). MDGL has higher revenues than GHRS: MDGL (317M) vs GHRS (0).
GHRSMDGLGHRS / MDGL
Capitalization699M6.07B12%
EBITDA-41.75M-376.15M11%
Gain YTD61.000-11.414-534%
P/E RatioN/AN/A-
Revenue0317M-
Total Cash291M843M35%
Total Debt658K120M1%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSMDGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSBJX22.85N/A
N/A
Principal SmallCap J
PJERX14.48N/A
N/A
PGIM Jennison Global Equity Income R
FTHSX43.66N/A
N/A
FullerThaler Behavioral Sm-Cp Eq Inst
GQHIX13.10N/A
N/A
GQG Partners US Quality Value Fund Ins
RYPDX125.95N/A
N/A
Rydex Consumer Products A

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-4.41%
MDGL - GHRS
43%
Loosely correlated
-1.40%
ATAI - GHRS
40%
Loosely correlated
+5.76%
IVVD - GHRS
38%
Loosely correlated
-0.52%
IBRX - GHRS
31%
Poorly correlated
+1.13%
ORMP - GHRS
31%
Poorly correlated
N/A
More